Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
group | 0.500 | None | 1.000 | 10 | 0 | 2000 | 2010 | ||||||||
|
butyrylcholinesterase | 0.447 | 0.923 | 1.1E-13 |
|
group | 0.300 | None | 1.000 | 8 | 0 | 2008 | 2015 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
group | 0.300 | None | 1.000 | 7 | 0 | 2004 | 2010 | ||||||||
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
group | 0.300 | None | 1.000 | 5 | 0 | 1999 | 2010 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
group | 0.500 | None | 1.000 | 5 | 0 | 1995 | 2009 | ||||||||
|
glutamate ionotropic receptor AMPA type subunit 1 | 0.570 | 0.577 | 1.00 |
|
group | 0.300 | None | 1.000 | 5 | 0 | 2003 | 2008 | ||||||||
|
prodynorphin | 0.535 | 0.577 | 1.7E-04 |
|
group | 0.300 | None | 1.000 | 4 | 0 | 2005 | 2009 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
group | 0.300 | None | 1.000 | 4 | 0 | 2002 | 2009 | ||||||||
|
FosB proto-oncogene, AP-1 transcription factor subunit | 0.463 | 0.846 | 0.98 |
|
group | 0.300 | None | 1.000 | 4 | 0 | 2003 | 2009 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
group | 0.300 | None | 1.000 | 4 | 0 | 2001 | 2009 | ||||||||
|
dopamine receptor D1 | 0.529 | 0.808 | 0.96 |
|
group | 0.300 | None | 1.000 | 4 | 0 | 2004 | 2010 | ||||||||
|
Fos proto-oncogene, AP-1 transcription factor subunit | 0.411 | 0.885 | 0.26 |
|
group | 0.300 | None | 1.000 | 3 | 0 | 2007 | 2009 | ||||||||
|
cAMP responsive element binding protein 1 | 0.463 | 0.885 | 1.00 |
|
group | 0.300 | None | 1.000 | 3 | 0 | 2001 | 2009 | ||||||||
|
neuropeptide S | 0.619 | 0.615 | 1.4E-04 |
|
group | 0.300 | None | 1.000 | 3 | 0 | 2009 | 2011 | ||||||||
|
early growth response 1 | 0.433 | 0.923 | 0.35 |
|
group | 0.500 | None | 1.000 | 3 | 0 | 2005 | 2014 | ||||||||
|
hypocretin receptor 1 | 0.623 | 0.654 | 1.7E-04 |
|
group | 0.300 | None | 1.000 | 3 | 0 | 2005 | 2010 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
group | 0.300 | None | 1.000 | 3 | 0 | 2001 | 2009 | ||||||||
|
opioid receptor mu 1 | 0.457 | 0.808 | 7.9E-11 |
|
group | 0.300 | None | 1.000 | 3 | 0 | 2003 | 2008 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
group | 0.300 | None | 1.000 | 3 | 0 | 2006 | 2009 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha2 | 0.641 | 0.346 | 1.00 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2010 | ||||||||
|
glial cell derived neurotrophic factor | 0.434 | 0.885 | 0.20 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2003 | 2005 | ||||||||
|
homer scaffold protein 1 | 0.636 | 0.538 | 1.00 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2005 | 2006 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 1 | 0.561 | 0.692 | 0.98 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2005 | 2010 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2003 | 2009 | ||||||||
|
sigma non-opioid intracellular receptor 1 | 0.544 | 0.808 | 0.17 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2003 | 2006 |